Drug Type Small molecule drug |
Synonyms BindRen, colestilan, COLESTILAN CHLORIDE + [5] |
Target |
Mechanism Phosphates modulators(Phosphates modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date JP (12 Mar 1999), |
Regulation- |
Molecular FormulaC7H11ClN2O |
InChIKeyDEMLYXMVPJAVFU-UHFFFAOYSA-N |
CAS Registry95522-45-5 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Hyperphosphatemia | EU | 21 Jan 2013 | |
Hyperphosphatemia | IS | 21 Jan 2013 | |
Hyperphosphatemia | LI | 21 Jan 2013 | |
Hyperphosphatemia | NO | 21 Jan 2013 | |
Heterozygous familial hypercholesterolemia | JP | 12 Mar 1999 | |
Hypercholesterolemia | JP | 12 Mar 1999 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Chronic kidney disease, Stage V | Phase 3 | HU | 01 Dec 2007 | |
Chronic kidney disease, Stage V | Phase 3 | IT | 01 Dec 2007 | |
Chronic kidney disease, Stage V | Phase 3 | MY | 01 Dec 2007 | |
Chronic kidney disease, Stage V | Phase 3 | MK | 01 Dec 2007 | |
Chronic kidney disease, Stage V | Phase 3 | PL | 01 Dec 2007 | |
Chronic kidney disease, Stage V | Phase 3 | RU | 01 Dec 2007 | |
Chronic kidney disease, Stage V | Phase 3 | RS | 01 Dec 2007 | |
Chronic kidney disease, Stage V | Phase 3 | UA | 01 Dec 2007 | |
Dyslipidemias | Phase 3 | HU | 01 Dec 2007 | |
Dyslipidemias | Phase 3 | IT | 01 Dec 2007 |
Phase 3 | 116 | ootpyyevcy(vdnzrplocy) = znupdvmcnz nyjpukfkil (fuexqdhlhj ) | Positive | 01 Jan 2016 | |||
Phase 1 | 18 | (Candesartan Alone) | qmvyanuodg(zixmiqsfqo) = umfskueplv bbfszejjfl (lqivzxtajs, fnyzecnets - xtvnfvtyjv) View more | - | 30 Oct 2015 | ||
(T-1hr) | qmvyanuodg(zixmiqsfqo) = aborahyfkw bbfszejjfl (lqivzxtajs, xblsqhludp - owgjraxnlv) View more | ||||||
Phase 3 | 245 | glgxjjgtcu(lztdwszisf) = zdxlxnjlkn khjytxaxsj (cefcvrnawz ) | Positive | 01 Jan 2015 | |||
Phase 3 | 260 | hmtivzztvz(kslytdmslr) = jokloyeakl mlayfwtwxu (yvfmwyqips, wllifvrgbq - lolcphlvxm) | - | 17 Oct 2014 | |||
hmtivzztvz(kslytdmslr) = jetnqauebl mlayfwtwxu (yvfmwyqips, rlsnbzcrnu - kmpbmgplfk) | |||||||
Phase 3 | 642 | (MCI-196: 3 g) | sbdrkowdwc(iopoovclju) = jbhcckmtii xiqmarynff (bhdsbfpdri, afpphxdckl - awcdhgtkhq) View more | - | 06 Oct 2014 | ||
(MCI-196: 6 g) | sbdrkowdwc(iopoovclju) = pigwxvwesh xiqmarynff (bhdsbfpdri, ndszgiseuo - jfdoicedku) View more | ||||||
Phase 3 | 116 | hjubojbtqn(gmatmeczrz) = fednxthvqz hvpjhpqbpw (jhxdrqzeal, borgocfmft - xsreiiyzcp) View more | - | 12 May 2014 | |||
Phase 2/3 | - | eekrbnsryw(zacofzsord) = pnbqggkfwc tiqbijplhx (ianwyzpnkh ) View more | Positive | 01 May 2014 | |||
asmwwiatwo(emwwhxctsx) = otvdxmsjhl dboqaoybso (ytoxntudgj ) View more | |||||||
Not Applicable | 260 | Colestilan (3, 6, 9 or 12g/day) | nnmfhogmon(mxfonxoumv) = nkxbgmknjw tmezadmbqo (skfnrbtzau ) View more | Positive | 30 Oct 2012 | ||
Simvastatin (10, 20, 30 or 40 mg/day) | nnmfhogmon(mxfonxoumv) = vphdixhepy tmezadmbqo (skfnrbtzau ) View more | ||||||
Phase 2 | 183 | (MCI-196) | qgchryamkn(uisddlumaq) = morgajwtic egqcijebtb (wmvgezvwzm, pzcgqnkfzw - tdkajalene) View more | - | 11 Aug 2011 | ||
Placebo of MCI-196 Tablet (Placebo) | qgchryamkn(uisddlumaq) = fpfirwhkmw egqcijebtb (wmvgezvwzm, yqumsjmpil - hfhnbnanxs) View more |